May 2026 exceptional surveillance of Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management (NICE guideline NG231)

In May 2026, we reviewed the existing recommendations on endoscopic surveillance.

Surveillance decision

We will update the guideline as published evidence indicates that the current recommendations regarding endoscopic surveillance are likely to need updating, with the potential for less use of an invasive procedure and associated cost-savings.

This page was last updated: